{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T16:06:00Z","timestamp":1790525160147,"version":"4.1.0"},"reference-count":16,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ther. Deliv."],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.4155\/tde.15.3","type":"journal-article","created":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T14:46:54Z","timestamp":1432219614000},"page":"419-422","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Buprenorphine: Revisiting the Efficacy of Transdermal Delivery System"],"prefix":"10.1080","volume":"6","author":[{"given":"Joseph P","family":"Kitzmiller","sequence":"first","affiliation":[{"name":"Department of Pharmacology, The Ohio State University College of Medicine, 5086 Graves Hall333 West Tenth Avenue, Columbus, OH, 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Barnett","sequence":"additional","affiliation":[{"name":"Temple University School of Medicine, 3500 North Broad Street, Philadelphia, PA, 19140, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan S","family":"Steiner","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine, 2900 West Queen Lane, Philadelphia, PA, 19129, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta","family":"Stoicea","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Wexner Medical Center, The Ohio State University, 410 West 10th Avenue, Columbus, OH, 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawal","family":"Kamar","sequence":"additional","affiliation":[{"name":"The Ohio State University, Columbus, OH, 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine A","family":"Luzum","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, The Ohio State University College of Medicine, 5086 Graves Hall333 West Tenth Avenue, Columbus, OH, 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Mikulik","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, The Ohio State University College of Medicine, 5086 Graves Hall333 West Tenth Avenue, Columbus, OH, 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio D","family":"Bergese","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Wexner Medical Center, The Ohio State University, 410 West 10th Avenue, Columbus, OH, 43210, USA"},{"name":"Department of Neurological Surgery, Wexner Medical Center, The Ohio State University, 410 West 10th Avenue, Columbus, OH, 43210, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/11208250-000000000-00000"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.06.015"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2741\/2147"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1191\/0269216306pm1126oa"},{"issue":"3","key":"e_1_3_3_6_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(24)35398-4","article-title":"Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?","volume":"292","author":"Zaki PA","year":"2000","unstructured":"Zaki PA Keith DE Jr Brine GA Carroll FI Evans CJ . Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation?J. Pharmacol. Exp. Ther.292 (3), 1127\u20131134 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2012.06.014"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.1980.tb08143.x"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0b013e3282f5272e"},{"key":"e_1_3_3_10_1","first-page":"93","volume-title":"Buprenorphine\u2013The unique opioid analgesic","author":"Budd K","year":"2005","unstructured":"Budd K Raffa RB . Transdermal Buprenorphine in Clinical Practice. In:Buprenorphine\u2013The unique opioid analgesic. BuddKRaffaRB (Eds). Thieme Medical Publishers, Berlin, Germany, 93\u2013101 (2005)."},{"issue":"5","key":"e_1_3_3_11_1","first-page":"171","article-title":"Transdermal drug delivery: principles and opioid therapy. Continuing Education in Anesthesia","volume":"7","author":"Margetts L","year":"2007","unstructured":"Margetts L Sawyer R . Transdermal drug delivery: principles and opioid therapy. Continuing Education in Anesthesia, Crit. Care Pain7 (5), 171\u2013176 (2007).","journal-title":"Crit. Care Pain"},{"issue":"9","key":"e_1_3_3_12_1","first-page":"583","article-title":"Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system","volume":"32","author":"Kapil RP","year":"2012","unstructured":"Kapil RP Cipriano A Michels GH et al. Effect of ketoconazole on the pharmacokinetic profile of buprenorphine following administration of a once-weekly buprenorphine transdermal system. Clin. Drug Investig.32 (9), 583\u2013592 (2012).","journal-title":"Clin. Drug Investig."},{"issue":"5","key":"e_1_3_3_13_1","first-page":"171","article-title":"Transdermal drug delivery: principles and opioid therapy. Continuing Education in Anesthesia","volume":"7","author":"Margetts L","year":"2007","unstructured":"Margetts L Sawyer R . Transdermal drug delivery: principles and opioid therapy. Continuing Education in Anesthesia, Crit. Care Pain7 (5), 171\u2013176 (2007).","journal-title":"Crit. Care Pain"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.09.016"},{"key":"e_1_3_3_15_1","volume-title":"Full Prescribing Information.","year":"2014","unstructured":"BUTRANS- buprenorphine patch, extended release. In:Full Prescribing Information.Purdue Pharma L.P., CT, USA (2014)."},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2011.06.003"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2011.04.006"}],"container-title":["Therapeutic Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/tde.15.3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T02:01:23Z","timestamp":1748397683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/tde.15.3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["10.4155\/tde.15.3"],"URL":"https:\/\/doi.org\/10.4155\/tde.15.3","relation":{},"ISSN":["2041-5990","2041-6008"],"issn-type":[{"value":"2041-5990","type":"print"},{"value":"2041-6008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=itde20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-05-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}